Number of the records: 1
A symposium
SYS c023153 LBL ^^^^^nam^^22^^^^^^^^450^ 005 20001123090957.0 100 $a 19990226d m y0sloc0103 ba 101 0-
$a eng 102 $a US 105 $a z 100yy 200 1-
$a <A> symposium $e endothelial function and cardiovascular disease $f edit. Carl J. Pepine $e potential mechanisms and interventions 210 $a New York $c Excerpta Medica $d 1998 215 $a 64 s. 225 2-
$a American Journal of Cardiology $v [Supl.] $x 0002-9149 541 1-
$a Sympózium: funkcia endotelu a kardiovaskulárneho ochorenia: potencionálne mechanizmy a intervencie 606 $a choroby kardiovaskulárne $x patofyziológia $2 mesh $3 sllk_un_auth*d002318 606 $a endotel cievny $2 mesh $3 sllk_un_auth*d004730 606 $3 sllk_un_auth*d007703 $a angiotenzín konvertujúci enzým $2 mesh 606 $3 sllk_un_auth*d000806 $a ACE inhibítory $2 mesh 606 $a oxid dusnatý $2 mesh $3 sllk_un_auth*d009569 606 $a oxid dusnatý $2 mesh $3 sllk_un_auth*d009569 606 $a endotelín-1 $2 mesh $3 sllk_un_auth*d019332 606 $a hypertenzia $2 mesh $3 sllk_un_auth*d006973 606 $3 sllk_un_auth*d006333 $a zlyhávanie srdca $2 mesh 606 $3 sllk_un_auth*d017202 $a choroba srdca, ischemická $x etiológia $2 mesh 606 $a choroba koronárna $x prevencia a kontrola $2 mesh $3 sllk_un_auth*d003327 606 $a inhibítory hydroxymetylglutaryl-CoA-reduktázy $x použitie terapeutické $2 mesh $3 sllk_un_auth*d019161 606 $a kyselina acetylsalicylová $2 mesh $3 sllk_un_auth*d001241 606 $a artérioskleróza $2 mesh $3 sllk_un_auth*d001161 606 $3 sllk_un_auth*d015316 $a terapia génová $2 mesh 606 $3 sllk_un_auth*d000806 $a ACE inhibítory $2 mesh 675 $a 616.12-008:616.13/.14 $v 1. stred. $z slo 702 -1
$a Pepine $b Carl J. $3 sllk_un_auth*p0004803 $4 340 801 -0
$a SK $b BA006 $c 19990226 $g AACR2
Number of the records: 1